ArticleCurrent oncology (Toronto, Ont.)2023

Injectable Synthetic Beta-Tricalcium Phosphate/Calcium Sulfate (GeneX) for the Management of Contained Defects Following Curettage of Benign Bone Tumours.

Nima Razii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.